Characterization of truncated forms of V2 vasopressin receptor

被引：0
|
作者：
Innamorati, G [1 ]
Sadeghi, H [1 ]
Birnbaumer, M [1 ]
机构：
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT ANESTHESIOL,LOS ANGELES,CA 90025
来源：
FASEB JOURNAL | 1996年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：2259 / 2259
页数：1
相关论文
共 50 条
  • [31] RENAL V2 VASOPRESSIN RECEPTOR PROTEINS - IDENTIFICATION AND ENRICHMENT
    FAHRENHOLZ, F
    KOJRO, E
    PLAGE, G
    MULLER, M
    JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (1-4): : 283 - 294
  • [32] Structural basis of tolvaptan binding to the vasopressin V2 receptor
    Liu, Hong-li
    Zhong, Hai-yang
    Zhang, Yi-xiao
    Xue, Hua-rui
    Zhang, Zheng-shuo
    Fu, Ke-quan
    Cao, Xu-dong
    Xiong, Xiao-chun
    Guo, Dong
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (11) : 2441 - 2449
  • [33] Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model
    Robben, JH
    Knoers, NVAM
    Deen, PMT
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (02) : F265 - F272
  • [34] CLONING AND CHARACTERIZATION OF A VASOPRESSIN V2 RECEPTOR AND POSSIBLE LINK TO NEPHROGENIC DIABETES-INSIPIDUS
    LOLAIT, SJ
    OCARROLL, AM
    MCBRIDE, OW
    KONIG, M
    MOREL, A
    BROWNSTEIN, MJ
    NATURE, 1992, 357 (6376) : 336 - 339
  • [35] Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise
    Hew-Butler, Tamara
    Hummel, Jed
    Rider, Brian C.
    Verbalis, Joseph G.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2014, 307 (04) : R366 - R375
  • [36] Conivaptan:: A dual receptor vasopressin V1a/V2 antagonist
    Ali, Farhan
    Raufi, M. Adnan
    Washington, Barbara
    Ghali, Jalal K.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (03): : 261 - 279
  • [37] Synthesis and characterization of orally active nonpeptide arginine vasopressin V2 receptor antagonist.
    Ohkawa, T
    Setoi, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 104 - MEDI
  • [38] Pharmacological characterization of RWJ-676070, a dual vasopressin V1A/V2 receptor antagonist
    Gunnet, Joseph W.
    Wines, Pamela
    Xiang, Min
    Rybczynski, Philip
    Andrade-Gordon, Patricia
    de Garavilla, Lawrence
    Parry, Tom J.
    Cheung, Wai-man
    Minor, Lisa
    Demarest, Keith T.
    Maryanoff, Bruce E.
    Damiano, Bruce P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 590 (1-3) : 333 - 342
  • [39] Identification and Characterization of an Activating F229V Substitution in the V2 Vasopressin Receptor in an Infant with NSIAD
    Carpentier, Eric
    Greenbaum, Larry A.
    Rochdi, Driss
    Abrol, Ravinder
    Goddard, William A., III
    Bichet, Daniel G.
    Bouvier, Michel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10): : 1635 - 1640
  • [40] Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresis
    Liu, Jun
    Sharma, Nikhil
    Zheng, Wei
    Ji, Hong
    Tam, Helen
    Wu, Xie
    Manigrasso, Michaele B.
    Sandberg, Kathryn
    Verbalis, Joseph G.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 300 (02) : F433 - F440
12345